ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: knee

Information on New Drug Approvals and Medication Safety

Michele B. Kaufman, PharmD, BCGP  |  March 8, 2012

Rheumatology-related drug safety, approvals, and what’s in the pipeline.

Filed under:Biologics/DMARDsConditionsDrug UpdatesGout and Crystalline Arthritis Tagged with:anti-inflammatoryBiologicscrystal arthritisdrugGoutJAK inhibitorsjanus kinaseMethotrexateRheumatoid arthritisrheumatologistSafetyTofacitinib

Epidemiologist Discusses Osteoarthritis Among Various Countries and Ethnic Groups

Staff  |  February 7, 2012

David T. Felson, MD, MPH, discusses his Beijing study that compared knee, hip, and hand osteoarthritis among Chinese to Caucasians in the Framingham study and the UCSF Study of Osteoporotic Fractures.

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:Osteoarthritis

A Patient’s Perspective on RA

Lisa C. Glavish  |  February 3, 2012

I was diagnosed in April 2010, at 44 years old, with seropositive RA; the disease rapidly turned my life upside down.

Filed under:ConditionsPatient PerspectivePractice SupportProfilesRheumatoid Arthritis Tagged with:drugMethotrexatePainpatient carePatientsprednisoneProfileRARheumatoid arthritisrheumatologist

A Passion for Multidisciplinary Collaboration

Gretchen Henkel  |  February 3, 2012

Through teamwork, David T. Felson, MD, MPH, has advanced understanding and treatment of rheumatic diseases

Filed under:ConditionsOsteoarthritis and Bone DisordersPractice SupportProfilesResearch RheumWorkforce Tagged with:BiomarkersCareerimagingOsteoarthritisOsteoporosisPractice ManagementProfileradiographResearchrheumatologistTraining

Arthritis in Winter

Sue Pondrom  |  January 18, 2012

Fewer daylight hours impact both RA and OA

Filed under:Conditions Tagged with:ArthritisExercise

A Short History of Rheumatoid Arthritis Therapeutics

Simon M. Helfgott, MD  |  January 13, 2012

Or, why I chose to become a rheumatologist

Filed under:Biologics/DMARDsConditionsDrug UpdatesOpinionProfilesResearch RheumRheumatoid ArthritisRheuminationsSpeak Out Rheum Tagged with:BiologicsdrugEducationHelfgottMethotrexateprednisoneProfileResearchresidencyRheumatoid arthritisrheumatologist

Dos and Don’ts of Verifying Insurance Benefits

Melesia Tillman, CPC-I, CRHC, CHA  |  January 13, 2012

Not verifying insurance benefits prior to rendering service can result in nonpayment, which affects your bottom line. Because this is a costly mistake that can be avoided, make it routine to verify eligibility prior to every patient visit.

Filed under:Billing/CodingFrom the CollegeInsurancePractice Support Tagged with:AC&RAmerican College of Rheumatology (ACR)BillingCodingdruginfliximabinsuranceMedicarePractice Managementrheumatologist

Chronic Osteoarthritic Pain Causes Brain Changes

Kathleen Louden  |  January 13, 2012

Theory of condition-specific ‘brain signature’ sparks controversy

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersPain SyndromesResearch Rheum Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)brainFibromyalgiaimagingOsteoarthritisPainPain Managementpatient careResearchrheumatologist

Foot Pain a Burden for Rheumatology Patients

Kathleen Louden  |  January 13, 2012

Researchers say it may even correlate with back, hip, and knee pain

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:ACR/ARHP Annual MeetingArthritisfeetOsteoarthritisPainpatient careResearchrheumatologist

A Celebration of Accomplishments

Richard Quinn  |  December 12, 2011

ARHP recognizes health professionals for their contributions to the field

Filed under:AwardsProfessional Topics Tagged with:2011 ACR/ARHP Annual Scientific MeetingAC&RAssociation of Rheumatology Professionals (ARP)Awards

  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 79
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences